Daniel S Graciaa

11PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsGenetic immunologyVenereologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 04, 2026
Distinct T cell correlates of COVID-19 risk before and after a second booster in previously SARS-CoV-2 infected versus naïve COVAIL trial participants.

|Jan 17, 2025
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.

Bo Zhang, Youyi Fong, Lauren Dang

|Oct 18, 2024
Systems Vaccinology: Navigating the Future of Personalized Immunity and Next-Generation Vaccines.

Serena Maria Dib, Sonia Wimalasena, Daniel S Graciaa

|Aug 28, 2023
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.

Angela R Branche, Nadine G Rouphael, David J Diemert

|May 19, 2023
Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial.

Angela Branche, Nadine Rouphael, David Diemert

|Dec 09, 2022
Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January-March 2021.

Daniel S Graciaa, Hans P Verkerke, Jeannette Guarner

Pageof 2

Frequent Collaborators

4 joint publications

David J Diemert

4 joint publications

Susan Little

4 joint publications

Angelica Kottkamp

4 joint publications

Dahlene N Fusco